0001615774-17-005667.txt : 20171010 0001615774-17-005667.hdr.sgml : 20171009 20171010160644 ACCESSION NUMBER: 0001615774-17-005667 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171010 DATE AS OF CHANGE: 20171010 EFFECTIVENESS DATE: 20171010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp. CENTRAL INDEX KEY: 0001430306 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261434750 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-296302 FILM NUMBER: 171130566 BUSINESS ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 1-800-849-7894 MAIL ADDRESS: STREET 1: 509 MADISON AVE. - SUITE 306 CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC. DATE OF NAME CHANGE: 20080320 D 1 primary_doc.xml X0708 D LIVE 0001430306 Tonix Pharmaceuticals Holding Corp. 509 MADISON AVENUE SUITE 306 NEW YORK NY NEW YORK 10022 (212) 980-9155 NEVADA TAMANDARE EXPLORATIONS INC. Tamandare Explorations Inc. TAMANDARE EXPLORATIONS INC. Corporation true Seth Lederman 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Executive Officer Director Chief Executive Officer, President and Chairman Bradley Saenger 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Executive Officer Chief Financial Officer, Treasurer Gregory Sullivan 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Executive Officer Chief Medical Officer, Secretary Margaret Smith Bell 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Stuart Davidson 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Patrick Grace 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Donald W. Landry 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Ernest Mario 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Charles E. Mather IV 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director John Rhodes 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Samuel Saks 509 Madison Avenue Suite 306 New York NY NEW YORK 10022 Director Pharmaceuticals Decline to Disclose 06b false 2017-09-28 true true false 0 15314798 314798 15000000 73,039 shares issued to Lincoln Park on 10/28/2017 as initial consideration for put right granted to the Company under the equity line agreement. Such shares are valued solely for purposes of this Form D at $4.31 (the closing stock price on 10/27/2017). false 1 0 0 0 false Tonix Pharmaceuticals Holding Corp. /s/ Bradley Saenger Bradley Saenger Chief Financial Officer 2017-10-10